Mustafin, C.; Vesnin, S.; Turnbull, A.; Dixon, M.; Goltsov, A.; Goryanin, I. Diagnostics of Ovarian Tumors in Postmenopausal Patients. Diagnostics2022, 12, 2619.
Mustafin, C.; Vesnin, S.; Turnbull, A.; Dixon, M.; Goltsov, A.; Goryanin, I. Diagnostics of Ovarian Tumors in Postmenopausal Patients. Diagnostics 2022, 12, 2619.
Mustafin, C.; Vesnin, S.; Turnbull, A.; Dixon, M.; Goltsov, A.; Goryanin, I. Diagnostics of Ovarian Tumors in Postmenopausal Patients. Diagnostics2022, 12, 2619.
Mustafin, C.; Vesnin, S.; Turnbull, A.; Dixon, M.; Goltsov, A.; Goryanin, I. Diagnostics of Ovarian Tumors in Postmenopausal Patients. Diagnostics 2022, 12, 2619.
Abstract
Ovarian cancer is the third most common female genital cancer. Therefore, the timely diagnosis and comprehensive treatment of postmenopausal patients with benign ovarian tumors remains crucial in the field of gynecology. The significance of ovarian tumors depends on their frequency and their effects on the quality of life of a woman, as well as the possible development of ovarian cancer. Most ovarian cancers are diagnosed late and as a result are difficult to treat and often carry a poor prognosis. Currently there is no clear algorithm available for examining and accurately diagnosing patients with postmenopausal ovarian tumors; moreover, reliable criteria allowing dynamic observation and determining surgical access and optimal surgical intervention measures in postmenopausal patients is lacking.
Keywords
microwave radiometry; postmenopausal; cancer biomarker
Subject
Medicine and Pharmacology, Oncology and Oncogenics
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
